• SENSEX
    NIFTY 50
Healthcare

Serum Institute of India gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccine

Updated : September 16, 2020 08:20 AM IST

SII has also been asked to submit to the DCGI's office details of medication used in accordance with the protocol for management of adverse events.
Serum Institute of India gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccine

You May Also Like

Live TV

recommended for you

Advertisement